Josef S Smolen

Josef S Smolen

UNVERIFIED PROFILE

Are you Josef S Smolen?   Register this Author

Register author
Josef S Smolen

Josef S Smolen

Publications by authors named "Josef S Smolen"

Are you Josef S Smolen?   Register this Author

100Publications

3417Reads

42Profile Views

Treat to Target in Rheumatology: A Historical Account on Occasion of the 10th Anniversary.

Authors:
Josef S Smolen

Rheum Dis Clin North Am 2019 Nov 16;45(4):477-485. Epub 2019 Aug 16.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2019.07.001DOI Listing
November 2019

Risk profiling for a refractory course of rheumatoid arthritis.

Semin Arthritis Rheum 2019 Oct 8;49(2):211-217. Epub 2019 Feb 8.

Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.02.004DOI Listing
October 2019

Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate- or methotrexate-treated rheumatoid arthritis patients in OPTIMA.

Clin Exp Rheumatol 2019 Sep-Oct;37(5):783-790. Epub 2019 Apr 9.

Division of Rheumatology and Clinical Immunology, Med. Klinik und Poliklinik IV, University of Munich, Germany.

View Article

Download full-text PDF

Source
October 2019

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

J Rheumatol 2019 Sep 15;46(9):1159-1163. Epub 2019 Jan 15.

From the Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; The Rheumatology Research Unit, Department of Rheumatology, Odense University Hospital; Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Children's Hospital of Eastern Ontario Research Institute; Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa, Ottawa; Institute for Work and Health, Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; Department of Epidemiology and Biostatistics; Amsterdam Rheumatology and Immunology Center; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam; Department of Rheumatology, and Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre; Care and Public Health Research Institute, Maastricht University, Maastricht; University of Twente, Department of Psychology, Health and Technology, Enschede, the Netherlands; Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles; Medicine Service, VA Medical Center, Birmingham; Department of Medicine, School of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; Department of Rehabilitation and Movement Science, College of Nursing and Health Sciences, University of Vermont, Burlington, Vermont; University of Washington, Seattle, Washington, USA; Swiss Paraplegic Research, Nottwil, Switzerland; Université de Lorraine, EA 4360 Approches Épidémiologiques et Psychologiques (APEMAC), Nancy, France; University of Florence, Florence, Italy; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria; European Medicines Agency, London, UK; Faculty of Medicine and Health University of Sydney and Department of Rheumatology, Royal North Shore Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181081DOI Listing
September 2019

Multimodal [ F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic Mice.

J Bone Miner Res 2019 Sep 30;34(9):1632-1645. Epub 2019 Jul 30.

Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.3748DOI Listing
September 2019

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.

Rheumatol Ther 2019 Sep 21;6(3):409-419. Epub 2019 Jun 21.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40744-019-0164-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702585PMC
September 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Ann Rheum Dis 2019 Sep 5;78(9):1151-1159. Epub 2019 Aug 5.

Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île deFrance, Cochin Hospital, Université Paris Descartes-Sorbonne Paris Cité, INSERM U1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214819DOI Listing
September 2019

Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.

Semin Arthritis Rheum 2019 Sep 19. Epub 2019 Sep 19.

Medical University of Vienna, Waehringer, Guertel 18-20, A-1090, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.09.005DOI Listing
September 2019

Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?

Rheum Dis Clin North Am 2019 Aug 5;45(3):315-324. Epub 2019 Jun 5.

Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Spitalgasse 23, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2019.04.002DOI Listing
August 2019

Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets.

Nat Rev Rheumatol 2019 Aug 19. Epub 2019 Aug 19.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41584-019-0279-6DOI Listing
August 2019

Rheumatoid arthritis disease activity and the risk of aseptic arthroplasty loosening.

Semin Arthritis Rheum 2019 Aug 1. Epub 2019 Aug 1.

Department of Medicine 3, Medical University of Vienna, Division of Rheumatology, Waehringer Guertel 18-20, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.07.011DOI Listing
August 2019

To DAPSA or not to DAPSA? That is not the question.

Ann Rheum Dis 2019 Jul 5;78(7):e61. Epub 2018 May 5.

Department of Rheumatology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-213548DOI Listing
July 2019

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

J Rheumatol 2019 Jul 15;46(7):721-726. Epub 2018 Dec 15.

From the Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, Mount Sinai Hospital, Toronto; University Health Network, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Michigan, Ann Arbor, Michigan; University of California, Los Angeles, Los Angeles; University of California, San Francisco, California; Brigham and Women's Hospital, Boston; Harvard Medical School, Boston, Massachusetts; Medical University of South Carolina, Charleston, South Carolina; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Hospital Clínic, Barcelona, Spain; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île de France, Paris; Université Paris Descartes-Sorbonne Paris Cité, Paris; INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin; Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin; University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; National and Kapodestrian University of Athens, and Biomedical Research Foundation of the Athens Academy, Athens, Greece; Department of Medicine, University of Cambridge, Cambridge, UK; University of Pisa, Pisa, Italy; Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180478DOI Listing
July 2019

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.

Arthritis Res Ther 2019 Jul 5;21(1):164. Epub 2019 Jul 5.

Leeds Biomedical Research Centre, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1937-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610967PMC
July 2019

Greetings from the editor.

Authors:
Josef S Smolen

Ann Rheum Dis 2019 Jun;78(6):715

Rheumatology, Medical University of Vienna, Vienna 1090, Austria

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2019-215621DOI Listing
June 2019

Impact of flare on radiographic progression after etanercept continuation, tapering or withdrawal in patients with rheumatoid arthritis.

Rheumatology (Oxford) 2019 Jun 30. Epub 2019 Jun 30.

Global Medical Affairs, Pfizer, Collegeville, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez224DOI Listing
June 2019

Era of biosimilars in rheumatology: reshaping the healthcare environment.

RMD Open 2019 21;5(1):e000900. Epub 2019 May 21.

Medical Affairs, Samsung Bioepis Co Ltd, Incheon, Korea (the Republic of).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2019-000900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560670PMC
May 2019

Effects of a brief workplace-centered consultation for employees with musculoskeletal pain on health outcomes: a prospective cohort study.

Sci Rep 2019 Apr 10;9(1):5867. Epub 2019 Apr 10.

Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-42387-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458179PMC
April 2019

I would never take preventive medication! Perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis.

Arthritis Care Res (Hoboken) 2019 Feb 2. Epub 2019 Feb 2.

Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23841DOI Listing
February 2019

Achieving Clinical Remission for Patients With Rheumatoid Arthritis.

JAMA 2019 02;321(5):457-458

Division of Rheumatology, Department of Medicine, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.21249DOI Listing
February 2019

Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment.

J Rheumatol 2019 Jan 15;46(1):7-18. Epub 2018 Sep 15.

From the Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria; Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA; Division of Rheumatology, Department of Internal Medicine, Keio University, Tokyo, Japan; Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA; Lilly Research Laboratories, Eli Lilly and Co., Kobe, Japan; Oregon Health Sciences University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.171361
Publisher Site
http://dx.doi.org/10.3899/jrheum.171361DOI Listing
January 2019

Greetings from the editor 2019.

Authors:
Josef S Smolen

Ann Rheum Dis 2019 01;78(1):1-2

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214822DOI Listing
January 2019

Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?

Ann Rheum Dis 2018 12 20;77(12):1736-1741. Epub 2018 Sep 20.

DANBIO, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2018-21346
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2018-213463DOI Listing
December 2018

Diagnosis and Management of Rheumatoid Arthritis: A Review.

JAMA 2018 Oct;320(13):1360-1372

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2018.13103DOI Listing
October 2018

Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.

Vaccine 2018 08 3;36(32 Pt B):4875-4879. Epub 2018 Jul 3.

Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2018.06.065DOI Listing
August 2018

Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.

Clin Exp Rheumatol 2018 May-Jun;36(3):362-370. Epub 2018 Feb 26.

Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
July 2018

The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.

Clin Exp Rheumatol 2018 Mar-Apr;36(2):275-283. Epub 2017 Dec 15.

Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre; and CAPHRI Research Institute, Maastricht University, The Netherlands.

View Article

Download full-text PDF

Source
June 2018

Early response to therapy predicts 6-month and 1-year disease activity outcomes in psoriatic arthritis patients.

Rheumatology (Oxford) 2018 06;57(6):969-976

Department of Rheumatology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key004DOI Listing
June 2018

Greetings from the editor.

Authors:
Josef S Smolen

Ann Rheum Dis 2018 06;77(6):789

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-213599DOI Listing
June 2018

Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.

RMD Open 2018 17;4(1):e000602. Epub 2018 Jun 17.

Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Free University and Humboldt University of Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2017-000602DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018870PMC
June 2018

Disease activity assessment in patients with psoriatic arthritis.

Best Pract Res Clin Rheumatol 2018 06 11;32(3):401-414. Epub 2018 Oct 11.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2018.08.004DOI Listing
June 2018

How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review.

Ann Rheum Dis 2018 05 5;77(5):782-783. Epub 2017 Jun 5.

Department of Rheumatology, Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211447DOI Listing
May 2018

Response to: 'The GRAPPA-OMERACT initiative to standardise outcomes in Psoriatic Arthritis clinical trials and longitudinal observational studies' by Tillet .

Ann Rheum Dis 2018 05 16;77(5):e24. Epub 2017 Aug 16.

UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS), Sorbonne Universités, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-212012DOI Listing
May 2018

mTOR Senses Environmental Cues to Shape the Fibroblast-like Synoviocyte Response to Inflammation.

Cell Rep 2018 05;23(7):2157-2167

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.04.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972226PMC
May 2018

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases.

Ann Rheum Dis 2018 02 2;77(2):165-174. Epub 2017 Sep 2.

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211937DOI Listing
February 2018

Rheumatoid arthritis.

Nat Rev Dis Primers 2018 02 8;4:18001. Epub 2018 Feb 8.

Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp20181
Publisher Site
http://dx.doi.org/10.1038/nrdp.2018.1DOI Listing
February 2018

Tofacitinib for Psoriatic Arthritis.

N Engl J Med 2018 02;378(8):775

Medical University of Vienna, Vienna, Austria

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1715189DOI Listing
February 2018

Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management.

Ann Rheum Dis 2018 Jan 2;77(1):18-20. Epub 2017 Aug 2.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211458DOI Listing
January 2018

Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä .

Ann Rheum Dis 2017 12 27;76(12):e50. Epub 2017 Apr 27.

Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211524DOI Listing
December 2017

The effects of structural damage on functional disability in psoriatic arthritis.

Ann Rheum Dis 2017 Dec 23;76(12):2038-2045. Epub 2017 Aug 23.

Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211433DOI Listing
December 2017

Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?' by Misra .

Ann Rheum Dis 2017 11 6;76(11):e48. Epub 2017 May 6.

Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211455DOI Listing
November 2017

The new editor greets you.

Authors:
Josef S Smolen

Ann Rheum Dis 2017 10;76(10):1636

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-212236DOI Listing
October 2017

Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis.

RMD Open 2017 10;3(2):e000546. Epub 2017 Oct 10.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2017-000546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640108PMC
October 2017

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis.

Rheumatology (Oxford) 2017 08;56(8):1251-1253

Division of Rheumatology, Allergy Immunology, University of California San Diego, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew390DOI Listing
August 2017

Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.

Nat Rev Rheumatol 2016 Dec 10;12(12):743-750. Epub 2016 Nov 10.

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; and at the 2nd Department of Medicine, Hietzing Hospital, Wolkersbergenstraße 1, 1130 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2016.183DOI Listing
December 2016

Advances in targeted therapy.

Rheumatology (Oxford) 2016 12;55(suppl 2):ii1-ii2

Rheumatology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew354DOI Listing
December 2016